GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Cash Flow for Dividends

Egyptian International Pharmaceutical Investments (CAI:PHAR) Cash Flow for Dividends : E£-434 Mil (TTM As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Cash Flow for Dividends?

Egyptian International Pharmaceutical Investments's cash flow for dividends for the three months ended in Sep. 2024 was E£-155 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was E£-434 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Egyptian International Pharmaceutical Investments's quarterly payment of dividends increased from Mar. 2024 (E£-8 Mil) to Jun. 2024 (E£-270 Mil) but then declined from Jun. 2024 (E£-270 Mil) to Sep. 2024 (E£-155 Mil).

Egyptian International Pharmaceutical Investments's annual payment of dividends increased from Dec. 2021 (E£-384 Mil) to Dec. 2022 (E£-393 Mil) but then declined from Dec. 2022 (E£-393 Mil) to Dec. 2023 (E£-310 Mil).


Egyptian International Pharmaceutical Investments Cash Flow for Dividends Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Cash Flow for Dividends Chart

Egyptian International Pharmaceutical Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -383.57 -393.14 -309.76

Egyptian International Pharmaceutical Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -101.17 -0.60 -8.07 -270.38 -155.00

Egyptian International Pharmaceutical Investments Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-434 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Egyptian International Pharmaceutical Investments Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Egyptian International Pharmaceutical Investments Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, P.O. Box 149 10th, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.

Egyptian International Pharmaceutical Investments Headlines